Filing Details

Accession Number:
0001638833-22-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-17 17:43:23
Reporting Period:
2022-03-15
Accepted Time:
2022-03-17 17:43:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638833 Surgery Partners Inc. SGRY Services-General Medical & Surgical Hospitals, Nec (8062) 473620923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1735766 George Goodwin C/O Surgery Partners, Inc.
310 Seven Springs Way, Suite 500
Brentwood TN 37027
President, Asc Group No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-15 7,761 $49.32 94,429 No 4 S Direct
Common Stock Acquisiton 2022-03-15 33,000 $13.42 127,429 No 4 M Direct
Common Stock Disposition 2022-03-15 18,786 $50.01 108,643 No 4 S Direct
Common Stock Disposition 2022-03-16 1,697 $50.88 106,946 No 4 S Direct
Common Stock Disposition 2022-03-16 12,500 $52.07 94,446 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-03-15 33,000 $13.42 33,000 $13.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
115,500 2021-12-31 2029-03-15 No 4 M Direct
Footnotes
  1. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.
  2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.